Publications 2023

Alonso-Alonso R, Rodríguez M, García-Díaz N, Tomás-Roca L, Borregón J, Cabezuelo-Rodríguez M, Rebollo-González M, Gallego-Manzano L, Cereceda L, Rodriguez-Pinilla SM, Córdoba R, Fernando García J, Torre-Castro J, García-Álvarez CM, Del Mar Onteniente Gomis M, Rivera-Díaz R, Rodriguez-Peralto JL, Vaqué JP, Ortiz-Romero PL, Piris MÁ (2023)
NanoString analysis of mycosis fungoides reveals individual molecular identity
Br J Dermatol, 188 (6), 812-814
DOI 10.1093/bjd/ljad061, PubMed 36881924

García-Díaz N, Wei Q, Taskén K (2023)
Small molecule inhibitors targeting regulatory T cells for cancer treatment
Eur J Immunol, 54 (2), e2350448
DOI 10.1002/eji.202350448, PubMed 37937687

Publications 2022

Ortiz-Romero PL, Maroñas Jiménez L, Muniesa C, Estrach T, Servitje O, Fernández-de-Misa R, Gallardo F, Sanmartín O, Riveiro-Falkenbach E, García-Díaz N, Vega R, Lora D, Postigo C, Jiménez B, Sánchez-Beato M, Pedro Vaqué J, Rodríguez Peralto JL, de la Cámara AG, de la Cruz J, Piris Pinilla MÁ (2022)
Activity and safety of topical pimecrolimus in patients with early stage mycosis fungoides (PimTo-MF): a single-arm, multicentre, phase 2 trial
Lancet Haematol, 9 (6), e425-e433
DOI 10.1016/S2352-3026(22)00107-7, PubMed 35654076

Publications 2021

García-Díaz N, Casar B, Alonso-Alonso R, Quevedo L, Rodríguez M, Ruso-Julve F, Esteve-Codina A, Gut M, Gru AA, González-Vela MC, Gut I, Rodriguez-Peralto JL, Varela I, Ortiz-Romero PL, Piris MA, Vaqué JP (2021)
PLCγ1/PKCθ Downstream Signaling Controls Cutaneous T-Cell Lymphoma Development and Progression
J Invest Dermatol, 142 (5), 1391-1400.e15
DOI 10.1016/j.jid.2021.09.024, PubMed 34687742

García-Díaz N, Piris MÁ, Ortiz-Romero PL, Vaqué JP (2021)
Mycosis Fungoides and Sézary Syndrome: An Integrative Review of the Pathophysiology, Molecular Drivers, and Targeted Therapy
Cancers (Basel), 13 (8)
DOI 10.3390/cancers13081931, PubMed 33923722

Publications 2020

Alonso-Alonso R, Mondéjar R, Martínez N, García-Diaz N, Pérez C, Merino D, Rodríguez M, Esteve-Codina A, Fuste B, Gut M, Burrows F, Scholz C, Vaqué JP, Gualberto A, Piris MÁ (2020)
Identification of tipifarnib sensitivity biomarkers in T-cell acute lymphoblastic leukemia and T-cell lymphoma
Sci Rep, 10 (1), 6721
DOI 10.1038/s41598-020-63434-5, PubMed 32317694

Publications 2019

Ruso-Julve F, Pombero A, Pilar-Cuéllar F, García-Díaz N, Garcia-Lopez R, Juncal-Ruiz M, Castro E, Díaz Á, Vazquez-Bourgón J, García-Blanco A, Garro-Martinez E, Pisonero H, Estirado A, Ayesa-Arriola R, López-Giménez J, Mayor F, Valdizán E, Meana J, Gonzalez-Maeso J, Martínez S, Vaqué JP, Crespo-Facorro B (2019)
Dopaminergic control of ADAMTS2 expression through cAMP/CREB and ERK: molecular effects of antipsychotics
Transl Psychiatry, 9 (1), 306
DOI 10.1038/s41398-019-0647-7, PubMed 31740729

Publications 2018

Llerena S, García-Díaz N, Curiel-Olmo S, Agraz-Doblas A, García-Blanco A, Pisonero H, Varela M, Santibáñez M, Almaraz C, Cereceda L, Martínez N, Arias-Loste MT, Puente Á, Martín-Ramos L, de Lope CR, Castillo-Suescun F, Cagigas-Fernandez C, Isidro P, Lopez-López C, Lopez-Hoyos M, Llorca J, Agüero J, Crespo-Facorro B, Varela I, Piris MÁ et al. (2018)
Applied diagnostics in liver cancer. Efficient combinations of sorafenib with targeted inhibitors blocking AKT/mTOR
Oncotarget, 9 (56), 30869-30882
DOI 10.18632/oncotarget.25766, PubMed 30112114

Publications 2016

Curiel-Olmo S, García-Castaño A, Vidal R, Pisonero H, Varela I, León-Castillo A, Trillo E, González-Vela C, García-Diaz N, Almaraz C, Moreno T, Cereceda L, Madureira R, Martinez N, Ortiz-Romero P, Valdizán E, Piris MA, Vaqué JP (2016)
Erratum: Individualized strategies to target specific mechanisms of disease in malignant melanoma patients displaying unique mutational signatures
Oncotarget, 7 (5), 6352
DOI 10.18632/oncotarget.7118, PubMed 26997263

Publications 2015

Curiel-Olmo S, García-Castaño A, Vidal R, Pisonero H, Varela I, León-Castillo A, Trillo E, González-Vela C, García-Diaz N, Almaraz C, Moreno T, Cereceda L, Madureira R, Martinez N, Ortiz-Romero P, Valdizán E, Piris MA, Vaqué JP (2015)
Individualized strategies to target specific mechanisms of disease in malignant melanoma patients displaying unique mutational signatures
Oncotarget, 6 (28), 25452-65
DOI 10.18632/oncotarget.4545, PubMed 26327537

Pérez C, González-Rincón J, Onaindia A, Almaráz C, García-Díaz N, Pisonero H, Curiel-Olmo S, Gómez S, Cereceda L, Madureira R, Hospital M, Suárez-Massa D, Rodriguez-Peralto JL, Postigo C, Leon-Castillo A, González-Vela C, Martinez N, Ortiz-Romero P, Sánchez-Beato M, Piris MÁ, Vaqué JP (2015)
Mutated JAK kinases and deregulated STAT activity are potential therapeutic targets in cutaneous T-cell lymphoma
Haematologica, 100 (11), e450-3
DOI 10.3324/haematol.2015.132837, PubMed 26294736